Abstract
Drug resistance is a major obstacle to successful cancer treatment. The identification of new approaches that can circumvent this problem will lead to improved clinical strategies and outcomes for cancer patients. MicroRNAs, key post-transcriptional gene regulators, are known to be master regulators of many cellular processes, including drug resistance. Drug resistance related microRNAs can be used to stratify patients and select those treatment options most likely to prove efficacious for a particular individual. This review summarizes the recent advances in drug resistance related microRNAs in cancer, and also analyzes the clinical and therapeutic applications they provide. We also envisage future developments toward the potential applications of these microRNAs to cancer treatment. In the future, more investigations should be performed to promote the success of therapeutic–clinical use of microRNAs in cancer.
Keywords: Cancer, drug resistance, microRNA.
Current Drug Targets
Title:Function of miRNA in Controlling Drug Resistance of Human Cancers
Volume: 14 Issue: 10
Author(s): Liu Hong, Zhiping Yang, Jiaojiao Ma and Daiming Fan
Affiliation:
Keywords: Cancer, drug resistance, microRNA.
Abstract: Drug resistance is a major obstacle to successful cancer treatment. The identification of new approaches that can circumvent this problem will lead to improved clinical strategies and outcomes for cancer patients. MicroRNAs, key post-transcriptional gene regulators, are known to be master regulators of many cellular processes, including drug resistance. Drug resistance related microRNAs can be used to stratify patients and select those treatment options most likely to prove efficacious for a particular individual. This review summarizes the recent advances in drug resistance related microRNAs in cancer, and also analyzes the clinical and therapeutic applications they provide. We also envisage future developments toward the potential applications of these microRNAs to cancer treatment. In the future, more investigations should be performed to promote the success of therapeutic–clinical use of microRNAs in cancer.
Export Options
About this article
Cite this article as:
Hong Liu, Yang Zhiping, Ma Jiaojiao and Fan Daiming, Function of miRNA in Controlling Drug Resistance of Human Cancers, Current Drug Targets 2013; 14 (10) . https://dx.doi.org/10.2174/13894501113149990183
DOI https://dx.doi.org/10.2174/13894501113149990183 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Call for Papers in Thematic Issues
New drug therapy for eye diseases
Eyesight is one of the most critical senses, accounting for over 80% of our perceptions. Our quality of life might be significantly affected by eye disease, including glaucoma, diabetic retinopathy, dry eye, etc. Although the development of microinvasive ocular surgery reduces surgical complications and improves overall outcomes, medication therapy is ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Review: Technegas - 99mTc-Metal Core Graphite Nanoparticles for Pulmonary Ventilation Imaging
Current Radiopharmaceuticals Synthesis and Evaluation of 99mTc Chelate-conjugated Bevacizumab
Current Radiopharmaceuticals CRISPR/Cas9 Genome Editing Tool: A Promising Tool for Therapeutic Applications on Respiratory Diseases
Current Gene Therapy Inhibition of Aurora A Kinase by Alisertib Induces Autophagy and Cell Cycle Arrest and Increases Chemosensitivity in Human Hepatocellular Carcinoma HepG2 Cells
Current Cancer Drug Targets Recent Patents Review in Three Dimensional Ultrasound Imaging
Recent Patents on Biomedical Engineering (Discontinued) Hydrogen Sulfide Regulates Intracellular Ca2+ Concentration in Endothelial Cells From Excised Rat Aorta
Current Pharmaceutical Biotechnology The Anti-Tumor Activity of Afatinib in Pancreatic Ductal Adenocarcinoma Cells
Anti-Cancer Agents in Medicinal Chemistry Angiogenesis Inhibitors and Radiation in Multimodality Cancer Therapy: Preclinical and Clinical Studies
Current Angiogenesis (Discontinued) Strategies for the Biological Evaluation of Gold Anticancer Agents
Anti-Cancer Agents in Medicinal Chemistry Current State of the Art of New Tubulin Inhibitors in the Clinic
Current Clinical Pharmacology Functions of S100 Proteins
Current Molecular Medicine Epivention: Epigenetic Based Cancer Chemoprevention
Epigenetic Diagnosis & Therapy (Discontinued) Chitosan Nanoparticles for Melanoma Cancer Treatment by Photodynamic Therapy and Electrochemotherapy Using Aminolevulinic Acid Derivatives
Current Medicinal Chemistry Combined Cancer Therapy with Non-Conventional Drugs: All Roads Lead to AMPK
Mini-Reviews in Medicinal Chemistry Patent Selections:
Recent Patents on Inflammation & Allergy Drug Discovery Potential Therapeutic Application of the Association of Vitamins C and K3 in Cancer Treatment
Current Medicinal Chemistry A Common Biological Mechanism in Cancer and Alzheimers Disease?
Current Alzheimer Research Purinergic Signalling: What is Missing and Needed Next? The Use of Transgenic Mice, Crystallographic Analysis and MicroRNA
CNS & Neurological Disorders - Drug Targets Recent Patents in Glycan-Based Cancer Biomarkers and Discovery Technologies
Recent Patents on Biomarkers The Role of Androgen Receptor Mutations in Prostate Cancer Progression
Current Genomics